EU GMP audit expected in Q1 FY27
Management expects the EUGMP audit to occur in April-June 2026, with most CAPA responses submitted.
Zim Laboratories · forward-looking guidance across the available source record.
Guidance tracker
Management expects the EUGMP audit to occur in April-June 2026, with most CAPA responses submitted.
Once EUGMP is cleared, NIP product revenue could scale to ₹20 crore+ per quarter, with agreements already in place.
Management targets 20% growth in emerging markets excluding Bangladesh, driven by new hires and product registrations.
A separate manufacturing block for a high-potential product will be converted into a site by March 2027, with MA expected within months.